Developer docs
API playgroundTry for free, no card

Search company profiles

Zyme Communications

Full company profile

uuid0028zcd

Namestring
Zyme Communications
Legal namestring
Zyme Communications Limited
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Zyme Communications is a privately held, UK-based specialist public relations and marketing communications agency focused exclusively on the life science sector. Founded in 2010 and headquartered in Cambridge with a second office in Manchester, the firm serves biotechnology, pharmaceutical, diagnostics, medical technology, and life sciences research companies across Europe and the United States, supporting both early-stage ventures and large multinationals. The senior team of approximately 15 specialists — including dedicated science writers and account directors with combined in-house and agency-side experience — positions the firm as a vertically deep alternative to generalist holding-company agencies.

The company offers four integrated service lines: PR & Media (press releases, article placement, media interviews, copywriting, social media management, and media training); Marketing (campaign development, market research, conference and trade show support, advertising, and lead generation); Design & Branding (website development, brand identity, print collateral, presentations, and video production); and Investor Relations (pitch deck creation, business plan development, and investor-targeted communications). Revenue is generated through project-based and retainer engagements typical of professional services agencies, with pricing tailored to client scope and budget and not publicly disclosed. Customer engagements often span multi-year corporate communications programmes, seed-to-Series-C funding announcement cycles, and ongoing brand-building initiatives.

Zyme differentiates itself through exclusive vertical focus on life sciences, an established international network of life science trade media contacts, and demonstrable placement in high-credibility publications including BioCentury, BioWorld, Drug Discovery World, Endpoints, GEN, and Pharmaceutical Technology. The company is independently owned with no parent entity, no disclosed external funding, and no subsidiaries. Recent 2026 industry recognition — including the Sifted UK & Ireland Leaderboard, Fierce Biotech Fierce 15, multiple Cambridge Independent and Business Weekly Awards, and European Mediscience Awards shortlists — indicates rising market visibility relative to peers in the specialist life science communications niche.

Short descriptiontext

Zyme Communications is a UK-based specialist PR and marketing communications agency serving life science companies across Europe and the USA, offering integrated PR, marketing, design, and investor relations services to both startups and multinationals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWaterbeach, United Kingdom
HQ citystring
Waterbeach
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science communications, public relations services, marketing communications, investor relations support, branding and design
Industry2 codes
PRIMARYBPAFADAJ
Healthcare & Life Sciences PR
SECONDARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies
NAICS code3 codes
  • Public Relations Agencies541820
  • Advertising Agencies541810
  • Advertising, Public Relations, and Related Services5418
SIC code2 codes
  • Services-Advertising Agencies7311
  • Services-Advertising7310
Product category
Public Relations Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1PR and Marketing Services
TypeProfessional Services
Description

Zyme Communications generates revenue by providing professional PR and marketing services to life science companies. Services include PR & Media, Marketing, Design & Branding, and Investor Relations support. Revenue is likely project-based or retainer arrangements typical of professional services agencies.

zymecommunications.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Zyme Communications provides PR and marketing services for the life science sector. The agency delivers four integrated service lines: PR & Media (press releases, article placement, media interviews, copywriting, social media management, media training), Marketing (campaign development, conference support, market research, lead generation), Design & Branding (website development, print collateral, brand identity, video production), and Investor Relations (pitch deck creation, investor-specific PR targeting life science trade and financial audiences). Services are tailored to biotech, pharma, diagnostics, and medical technology companies seeking to raise profile, build corporate value, and generate interest from commercial leads, investors, and partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Coverage in top target publications including BioCentury, BioWorld, Drug Discovery World, Endpoints, FirstWord Pharma, GEN, The Pharma Letter, MedNous, News Medical, Pharmaceutical Technology
+2 more records
Product overview1 text field

Zyme Communications is a specialist PR and marketing communications agency for the life science sector, providing a unified service offering rather than a software product. The company offers four integrated service lines: PR & Media (strategic communications, press releases, media relations, social media), Marketing (campaign development, lead generation, market research, event support), Design & Branding (website development, visual identity, presentations, video), and Investor Relations (pitch materials, investor-targeted communications). These services work together to help life science companies raise their profile, build corporate value, and generate interest from commercial leads, investors, and partners.

Product and service4 records
1PR & Media Services
CategoryPublic Relations
Description

Strategic communications support for life science companies, including press releases, article placement in trade publications, media interviews, copywriting, social media management, and media training designed to build visibility and drive coverage.

2Marketing Services
CategoryMarketing
Description

Comprehensive marketing services for life science clients, including conference and trade show support, marketing literature, market research, campaign development, advertising, sponsorship identification, and lead generation.

3Design & Branding Services
CategoryDesign and Branding
Description

Creative services for life science companies including website design and development, print collateral, brand identity and logo creation, presentation development, and video production.

4Investor Relations Services
CategoryInvestor Relations
Description

Communications support for life science investor engagement, including business plan development, pitch deck creation, and targeted PR aimed at life science trade media and financial audiences.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Makovsky
TypeDirect peer
Description

Makovsky is a US-based integrated communications firm with a strong health and life science practice. Comparable in offering PR, media relations, IR support, and brand communications to life science and healthcare clients.

2Canale Communications
TypeDirect peer
Description

Canale Communications is a US-based life science PR and marketing agency focused exclusively on biotech, pharma, and medtech. Direct competitor offering overlapping services (PR, IR, content) to similar startup and enterprise life science clients.

TypeBroad incumbent
Description

Edelman is the world's largest PR firm with a dedicated health and life science practice. Broad incumbent offering global scale and integrated communications that competes with specialist life science agencies on enterprise accounts.

TypeDirect peer
Description

LifeSci Communications is a specialist healthcare and life sciences PR and communications agency. Directly comparable in vertical focus and service mix (media relations, scientific communications, IR support) for life science clients.

TypeDirect peer
Description

ICR is a strategic communications and advisory firm with a dedicated healthcare and life sciences practice. Comparable in serving biotech clients with integrated PR and IR services, particularly around funding events and corporate milestones.

6Health Unlimited
TypeDirect peer
Description

Health Unlimited is a specialist health and life science communications agency within the larger Unlimited Group. Comparable in vertical focus on healthcare/life science PR, brand communications, and patient/stakeholder engagement.

TypeDirect peer
Description

BioStrata is a UK-based specialist life science marketing and PR agency. It is a direct peer given its highly comparable positioning as a specialist communications firm serving biotech and life science clients from a similar UK footprint.

TypeDirect peer
Description

Russo Partners is a life science and healthcare-focused PR agency. Direct peer offering media relations, IR communications, and corporate communications to biotech and medical technology clients, mirroring Zyme's specialist positioning.

TypeBroad incumbent
Description

Fishawack Health is a global healthcare communications group offering medical communications, PR, and consulting to pharma and biotech. Broader incumbent operating at significantly larger scale across multiple life science sub-segments.

TypeBroad incumbent
Description

Syneos Health is a large biopharmaceutical services organization with a communications arm serving life science clients. Broader incumbent competing in the same life science PR/marketing space with significantly greater scale and clinical services adjacency.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Zyme Communications

Public Relations Serviceszymecommunications.com

Zyme Communications is a UK-based specialist PR and marketing communications agency serving life science companies across Europe and the USA, offering integrated PR, marketing, design, and investor relations services to both startups and multinationals.

What Zyme Communications does

Zyme Communications is a privately held, UK-based specialist public relations and marketing communications agency focused exclusively on the life science sector. Founded in 2010 and headquartered in Cambridge with a second office in Manchester, the firm serves biotechnology, pharmaceutical, diagnostics, medical technology, and life sciences research companies across Europe and the United States, supporting both early-stage ventures and large multinationals. The senior team of approximately 15 specialists — including dedicated science writers and account directors with combined in-house and agency-side experience — positions the firm as a vertically deep alternative to generalist holding-company agencies.

The company offers four integrated service lines: PR & Media (press releases, article placement, media interviews, copywriting, social media management, and media training); Marketing (campaign development, market research, conference and trade show support, advertising, and lead generation); Design & Branding (website development, brand identity, print collateral, presentations, and video production); and Investor Relations (pitch deck creation, business plan development, and investor-targeted communications). Revenue is generated through project-based and retainer engagements typical of professional services agencies, with pricing tailored to client scope and budget and not publicly disclosed. Customer engagements often span multi-year corporate communications programmes, seed-to-Series-C funding announcement cycles, and ongoing brand-building initiatives.

Zyme differentiates itself through exclusive vertical focus on life sciences, an established international network of life science trade media contacts, and demonstrable placement in high-credibility publications including BioCentury, BioWorld, Drug Discovery World, Endpoints, GEN, and Pharmaceutical Technology. The company is independently owned with no parent entity, no disclosed external funding, and no subsidiaries. Recent 2026 industry recognition — including the Sifted UK & Ireland Leaderboard, Fierce Biotech Fierce 15, multiple Cambridge Independent and Business Weekly Awards, and European Mediscience Awards shortlists — indicates rising market visibility relative to peers in the specialist life science communications niche.

Zyme Communications firmographics

Firmographics
Name
Zyme Communications
Legal name
Zyme Communications Limited
Website
https://zymecommunications.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
Zyme Communications is a UK-based specialist PR and marketing communications agency serving life science companies across Europe and the USA, offering integrated PR, marketing, design, and investor relations services to both startups and multinationals.
Ownership category
akta.pro rank

Zyme Communications industry classification

Industry
Product category
Public Relations Services
NAICS
Public Relations Agencies (541820), Advertising Agencies (541810), Advertising, Public Relations, and Related Services (5418)
SIC
Services-Advertising Agencies (7311), Services-Advertising (7310)
akta.pro industry
PRIMARYBPAFADAJ
Healthcare & Life Sciences PR
SECONDARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies

Keywords

  • Life science communications
  • Public relations services
  • Marketing communications
  • Investor relations support
  • Branding and design

Where Zyme Communications is headquartered

Location

Headquarters

HQ city
Waterbeach
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Zyme Communications business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. PR and Marketing Services: Zyme Communications generates revenue by providing professional PR and marketing services to life science companies. Services include PR & Media, Marketing, Design & Branding, and Investor Relations support. Revenue is likely project-based or retainer arrangements typical of professional services agencies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Zyme Communications product offering

Product offering

Core offering

Zyme Communications provides PR and marketing services for the life science sector. The agency delivers four integrated service lines: PR & Media (press releases, article placement, media interviews, copywriting, social media management, media training), Marketing (campaign development, conference support, market research, lead generation), Design & Branding (website development, print collateral, brand identity, video production), and Investor Relations (pitch deck creation, investor-specific PR targeting life science trade and financial audiences). Services are tailored to biotech, pharma, diagnostics, and medical technology companies seeking to raise profile, build corporate value, and generate interest from commercial leads, investors, and partners.

Product overview

Zyme Communications is a specialist PR and marketing communications agency for the life science sector, providing a unified service offering rather than a software product. The company offers four integrated service lines: PR & Media (strategic communications, press releases, media relations, social media), Marketing (campaign development, lead generation, market research, event support), Design & Branding (website development, visual identity, presentations, video), and Investor Relations (pitch materials, investor-targeted communications). These services work together to help life science companies raise their profile, build corporate value, and generate interest from commercial leads, investors, and partners.

Differentiator

Problem solved

Functional benefit

Products and services

  • PR & Media Services Strategic communications support for life science companies, including press releases, article placement in trade publications, media interviews, copywriting, social media management, and media training designed to build visibility and drive coverage.
  • Marketing Services Comprehensive marketing services for life science clients, including conference and trade show support, marketing literature, market research, campaign development, advertising, sponsorship identification, and lead generation.
  • Design & Branding Services Creative services for life science companies including website design and development, print collateral, brand identity and logo creation, presentation development, and video production.
  • Investor Relations Services Communications support for life science investor engagement, including business plan development, pitch deck creation, and targeted PR aimed at life science trade media and financial audiences.

Quantifiable outcome

  • Coverage in top target publications including BioCentury, BioWorld, Drug Discovery World, Endpoints, FirstWord Pharma, GEN, The Pharma Letter, MedNous, News Medical, Pharmaceutical Technology
  • +2 more outcomes

Companies that use Zyme Communications

Customer profile

Named customers12 records

Segments1 record

Ideal customer profiles2 records

Zyme Communications technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Zyme Communications partnerships and signals

Strategic signal

Scale indicators2 records

Expansion highlights6 records

Zyme Communications competitors and assessment

Company assessment

Direct peers

  • Makovsky: Makovsky is a US-based integrated communications firm with a strong health and life science practice. Comparable in offering PR, media relations, IR support, and brand communications to life science and healthcare clients.
  • Canale Communications: Canale Communications is a US-based life science PR and marketing agency focused exclusively on biotech, pharma, and medtech. Direct competitor offering overlapping services (PR, IR, content) to similar startup and enterprise life science clients.
  • LifeSci Communications: LifeSci Communications is a specialist healthcare and life sciences PR and communications agency. Directly comparable in vertical focus and service mix (media relations, scientific communications, IR support) for life science clients.
  • ICR (Westwicke): ICR is a strategic communications and advisory firm with a dedicated healthcare and life sciences practice. Comparable in serving biotech clients with integrated PR and IR services, particularly around funding events and corporate milestones.
  • Health Unlimited: Health Unlimited is a specialist health and life science communications agency within the larger Unlimited Group. Comparable in vertical focus on healthcare/life science PR, brand communications, and patient/stakeholder engagement.
  • BioStrata: BioStrata is a UK-based specialist life science marketing and PR agency. It is a direct peer given its highly comparable positioning as a specialist communications firm serving biotech and life science clients from a similar UK footprint.
  • Russo Partners: Russo Partners is a life science and healthcare-focused PR agency. Direct peer offering media relations, IR communications, and corporate communications to biotech and medical technology clients, mirroring Zyme's specialist positioning.

Broad incumbents

  • Edelman: Edelman is the world's largest PR firm with a dedicated health and life science practice. Broad incumbent offering global scale and integrated communications that competes with specialist life science agencies on enterprise accounts.
  • Fishawack Health: Fishawack Health is a global healthcare communications group offering medical communications, PR, and consulting to pharma and biotech. Broader incumbent operating at significantly larger scale across multiple life science sub-segments.
  • Syneos Health Communications: Syneos Health is a large biopharmaceutical services organization with a communications arm serving life science clients. Broader incumbent competing in the same life science PR/marketing space with significantly greater scale and clinical services adjacency.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Zyme Communications social profiles

Digital presence

Zyme Communications financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Zyme Communications leadership team

Management profile

Number of profiles

Profiles5 records

Zyme Communications funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Zyme Communications M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zyme Communications

What does Zyme Communications do?

Zyme Communications provides PR and marketing services for the life science sector. The agency delivers four integrated service lines: PR & Media (press releases, article placement, media interviews, copywriting, social media management, media training), Marketing (campaign development, conference support, market research, lead generation), Design & Branding (website development, print collateral, brand identity, video production), and Investor Relations (pitch deck creation, investor-specific PR targeting life science trade and financial audiences). Services are tailored to biotech, pharma, diagnostics, and medical technology companies seeking to raise profile, build corporate value, and generate interest from commercial leads, investors, and partners.

Is Zyme Communications a public or private company?

Zyme Communications is a private company. It is classified as unknown and is currently operating.

When was Zyme Communications founded?

Zyme Communications was founded in 2010. It employs 11 to 50 people.

Where is Zyme Communications based?

Zyme Communications is headquartered in Waterbeach, United Kingdom, in the Europe region.

How does Zyme Communications make money?

One revenue line is on record: PR and Marketing Services.

Who are Zyme Communications's main competitors?

Direct peers on record are Makovsky, Canale Communications, LifeSci Communications, ICR (Westwicke), Health Unlimited, BioStrata and Russo Partners. Broad incumbents are Edelman, Fishawack Health and Syneos Health Communications.

Does Zyme Communications have an API?

No public API is recorded for Zyme Communications.

What industry is Zyme Communications in?

Zyme Communications's product category is Public Relations Services. Its primary akta.pro industry code is BPAFADAJ, Healthcare & Life Sciences PR, with a secondary code of MPAAADAD, Healthcare & Life Sciences PR. Its NAICS code is 541820 and its SIC code is 7311.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales